On this page
Honasa Buys 58% of Fluence Pharma for ₹135 Cr, Launches Honasa Health for Nutraceuticals
Our read
Honasa is bolting on a dermatologist-led nutraceuticals platform and standing up Honasa Health to operationalize a multi-brand B2C playbook across Hair Fact, Skin Fact, and Pro Fact.
Ask next
The report,
Honasa Consumer, parent of Mamaearth, will acquire 58% of nutraceuticals firm Fluence Pharma for ₹135 crore, with remaining 42% over 5-7 years. It also approved a wholly owned subsidiary Honasa Health for B2C nutraceuticals.
Reported figures
From the report. Source details below
- 3,000+ dermatologists
- FY25 revenue ₹37.21 cr
- share price ₹415.90
Why it matters to operators
The phased 58/42 structure with a 5-7 year tail is a textbook earn-in template for founder-led health assets—worth benchmarking for any nutraceuticals or derma-adjacent targets in the pipeline.
The source
Published
Confirmed by Entrackr, ET Small Business, Mint, Inc42, NDTV Profit, The Hindu BusinessLine, Moneycontrol
First seen